1. Efficacy of a bruton’s tyrosine kinase Inhibitor (PRN-473) in the treatment of canine pemphigus foliaceus;Goodale;Vet Dermatol,2020
2. Open trial of bruton’s tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus;Goodale;Vet Dermatol,2020
3. Bruton tyrosine kinase inhibitors for multiple sclerosis;Krämer;Nat Rev Neurol,2023
4. Efficacy and safety of rilzabrutinib in pemphigus: PEGASUS phase 3 randomized study;Murrell;J Invest Dermatol,2024
5. Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study;Murrell;Br J Dermatol,2021